FDA Inspection
Fresenius Kabi Compounding, LLCFresenius Kabi Compounding, LLC – FDA Inspection, Nov 5, 2025
Record Details
This FDA Inspection record concerns Fresenius Kabi Compounding, LLC, with an inspection on November 5, 2025, issued by the New England District Office, covering human drugs.
View Company Profile
ID · 1d24adc1-59f9-4325-8055-4af95ddacd37
Inspection Facts
- Inspection number
- 1290368
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
7- 21 CFR 211.110(b)In-process conformity - examination, sample testing
- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
- 21 CFR 211.42(c)(10)(v)Cleaning System
- 21 CFR 211.58Buildings not maintained in good state of repair
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Fresenius Kabi Compounding, LLC
2| Date | Classification | Office | Project area |
|---|---|---|---|
| March 6, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 4, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Fresenius Kabi Compounding, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.